Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1990 1
2002 1
2003 1
2006 1
2012 2
2013 2
2015 2
2016 2
2017 4
2018 3
2019 1
2020 6
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
The coming of age of engineered multivalent antibodies.
Nuñez-Prado N, Compte M, Harwood S, Álvarez-Méndez A, Lykkemark S, Sanz L, Álvarez-Vallina L. Nuñez-Prado N, et al. Among authors: harwood s. Drug Discov Today. 2015 May;20(5):588-94. doi: 10.1016/j.drudis.2015.02.013. Epub 2015 Mar 7. Drug Discov Today. 2015. PMID: 25757598 Review.
Cell polarity and Dictyostelium development.
Williams HP, Harwood AJ. Williams HP, et al. Curr Opin Microbiol. 2003 Dec;6(6):621-7. doi: 10.1016/j.mib.2003.10.008. Curr Opin Microbiol. 2003. PMID: 14662359 Review.
Chemotaxis during early development requires each cell to rapidly reorganize its cytoskeleton to point towards a source of cAMP. This involves a balance between local induction of F-actin polymerization and suppression of pseudopods that point in other directions. ...Durin …
Chemotaxis during early development requires each cell to rapidly reorganize its cytoskeleton to point towards a source of cAMP. This involv …
Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies.
Mikkelsen K, Harwood SL, Compte M, Merino N, Mølgaard K, Lykkemark S, Alvarez-Mendez A, Blanco FJ, Álvarez-Vallina L. Mikkelsen K, et al. Among authors: harwood sl. Front Immunol. 2019 Jul 31;10:1791. doi: 10.3389/fimmu.2019.01791. eCollection 2019. Front Immunol. 2019. PMID: 31417564 Free PMC article.
We have recently generated an EGFR-targeted 4-1BB-agonistic trimerbody that demonstrated strong antitumor activity and did not induce systemic inflammatory cytokine secretion and hepatotoxicity associated with first-generation 4-1BB agonists. ...
We have recently generated an EGFR-targeted 4-1BB-agonistic trimerbody that demonstrated strong antitumor activity and did not induce system …
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR.
Compte M, Harwood SL, Martínez-Torrecuadrada J, Perez-Chacon G, González-García P, Tapia-Galisteo A, Van Bergen En Henegouwen PMP, Sánchez A, Fabregat I, Sanz L, Zapata JM, Alvarez-Vallina L. Compte M, et al. Among authors: harwood sl. Front Immunol. 2021 Jan 7;11:614363. doi: 10.3389/fimmu.2020.614363. eCollection 2020. Front Immunol. 2021. PMID: 33488625 Free PMC article.
A systematic review of muscle morphology and function in intermittent claudication.
Harwood AE, King S, Totty J, Smith GE, Vanicek N, Chetter IC. Harwood AE, et al. J Vasc Surg. 2017 Oct;66(4):1241-1257. doi: 10.1016/j.jvs.2017.05.106. Epub 2017 Aug 16. J Vasc Surg. 2017. PMID: 28822657 Free article. Review.
There were four main categories of functional outcome measures: muscle strength, muscle size, muscle fiber type, and muscle metabolism. A total of 2837 patients were included in the study. Nine studies reported on muscle strength, incorporating isometric, concentric, eccen …
There were four main categories of functional outcome measures: muscle strength, muscle size, muscle fiber type, and muscle metabolism
34 results